153 related articles for article (PubMed ID: 8353040)
1. Intra-tumoral heterogeneity of tumour potential doubling times (Tpot) in colorectal cancer.
Wilson MS; West CM; Wilson GD; Roberts SA; James RD; Schofield PF
Br J Cancer; 1993 Sep; 68(3):501-6. PubMed ID: 8353040
[TBL] [Abstract][Full Text] [Related]
2. Relationship between potential doubling time (Tpot), labeling index and duration of DNA synthesis in 60 esophageal and 35 breast tumors: Is it worthwhile to measure Tpot?
Haustermans K; Fowler J; Geboes K; Christiaens MR; Lerut A; van der Schueren E
Radiother Oncol; 1998 Feb; 46(2):157-67. PubMed ID: 9510043
[TBL] [Abstract][Full Text] [Related]
3. An assessment of the reliability and reproducibility of measurement of potential doubling times (Tpot) in human colorectal cancers.
Wilson MS; West CM; Wilson GD; Roberts SA; James RD; Schofield PF
Br J Cancer; 1993 Apr; 67(4):754-9. PubMed ID: 8471432
[TBL] [Abstract][Full Text] [Related]
4. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.
Tsang RW; Fyles AW; Kirkbride P; Levin W; Manchul LA; Milosevic MF; Rawlings GA; Banerjee D; Pintilie M; Wilson GD
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1319-29. PubMed ID: 7635771
[TBL] [Abstract][Full Text] [Related]
5. Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations.
Begg AC; Moonen L; Hofland I; Dessing M; Bartelink H
Radiother Oncol; 1988 Apr; 11(4):337-47. PubMed ID: 3375460
[TBL] [Abstract][Full Text] [Related]
6. [In vivo evaluation of potential doubling time (Tpot) of tumors by flow cytometry: practical difficulties and possible solutions].
Gorisse MC; Desoize B; Carpentier Y; Nguyen TD
Bull Cancer; 1996 Oct; 83(10):825-34. PubMed ID: 8952632
[TBL] [Abstract][Full Text] [Related]
7. Pre-operative kinetic parameter determination of colorectal adenocarcinomas. Prognostic significance.
Michel P; Paresy M; Lepessot F; Hellot MF; Paillot B; Scotte M; Peillon C; Ducrotté P; Hemet J
Eur J Gastroenterol Hepatol; 2000 Mar; 12(3):275-80. PubMed ID: 10750646
[TBL] [Abstract][Full Text] [Related]
8. Do cell kinetics have prognostic and/or predictive value in oesophageal cancer treated by surgery?
Haustermans K; Fowler F; Geboes K; Lerut T; van der Schueren E
Eur J Surg Oncol; 1997 Aug; 23(4):293-7. PubMed ID: 9315055
[TBL] [Abstract][Full Text] [Related]
9. Systematic heterogeneity and prognostic significance of cell proliferation in colorectal cancer.
Palmqvist R; Oberg A; Bergström C; Rutegård JN; Zackrisson B; Stenling R
Br J Cancer; 1998 Mar; 77(6):917-25. PubMed ID: 9528835
[TBL] [Abstract][Full Text] [Related]
10. Cellular kinetics in rectal cancer.
Terry NH; Meistrich ML; Roubein LD; Lynch PM; Dubrow RA; Rich TA
Br J Cancer; 1995 Aug; 72(2):435-41. PubMed ID: 7640229
[TBL] [Abstract][Full Text] [Related]
11. Tumour cell repopulation during fractionated radiotherapy: correlation between flow cytometric and radiobiological data in three murine tumours.
Begg AC; Hofland I; Kummermehr J
Eur J Cancer; 1991; 27(5):537-43. PubMed ID: 1828958
[TBL] [Abstract][Full Text] [Related]
12. [Clinical value of the potential doubling time (Tpot) measured by flow cytometry].
Dubray B; Maciorowsky Z; Cosset JM; Terry NH
Bull Cancer; 1995; 82(5):331-8. PubMed ID: 7626840
[TBL] [Abstract][Full Text] [Related]
13. Effect of radiation therapy on the potential doubling time of tumours in colorectal cancers.
Michel P; Paresy M; Lepessot F; Mauillon J; Seng S; Scotte M; Peillon C; Ducrotté P; Hemet J; Paillot B
Eur J Gastroenterol Hepatol; 1999 Mar; 11(3):309-14. PubMed ID: 10333205
[TBL] [Abstract][Full Text] [Related]
14. [Cell kinetic analysis and treatment planning in epidermoid tumors of the head and neck].
Margarino G; Scala M; Schenone G; Mereu P; Corvo R; Sanguineti G; Giaretti W; Geido E; Orecchia R; Meszaros P
Acta Otorhinolaryngol Ital; 1992; 12(5):421-33. PubMed ID: 1303006
[TBL] [Abstract][Full Text] [Related]
15. Assessment of human tumour proliferation using bromodeoxyuridine--current status.
Wilson GD
Acta Oncol; 1991; 30(8):903-10. PubMed ID: 1777243
[TBL] [Abstract][Full Text] [Related]
16. Cell proliferation kinetics in human tumor xenografts measured with iododeoxyuridine labeling and flow cytometry: a study of heterogeneity and a comparison between different methods of calculation and other proliferation measurements.
Perez LA; Dombkowski D; Efird J; Preffer F; Suit HD
Cancer Res; 1995 Jan; 55(2):392-8. PubMed ID: 7812972
[TBL] [Abstract][Full Text] [Related]
17. Is there a future for cell kinetic measurements using IdUrd or BdUrd?
Haustermans K; Fowler JF
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):505-11. PubMed ID: 11173147
[TBL] [Abstract][Full Text] [Related]
18. Proliferative characteristics of head and neck tumors. In vivo evaluation by bromodeoxyuridine incorporation and flow cytometry.
Benazzo M; Mevio E; Occhini A; Franchini G; Danova M
ORL J Otorhinolaryngol Relat Spec; 1995; 57(1):39-43. PubMed ID: 7700609
[TBL] [Abstract][Full Text] [Related]
19. Influence of sampling time on assessment of potential doubling time.
Høyer M; Bentzen SM; Salling LN; Overgaard J
Cytometry; 1994 Jun; 16(2):144-51. PubMed ID: 7924683
[TBL] [Abstract][Full Text] [Related]
20. Calculating potential doubling time using monoclonal antibodies specific for two halogenated thymidine analogues.
Pollack A; White RA; Cao S; Meistrich ML; Terry NH
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1131-9. PubMed ID: 8262838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
